Age Related Macula Degeneration - newly diagnosed and previously treated patients

Published by Auckland Eye on Thursday, 04 Jul 2019
155_1_lrgsize

The study compares two types of anti-Vascular Endothelial Growth Factor (anti-VEGF) injection treatments to the eye.


Inclusion Criteria:
•    Previous anti-VEGF treatment for AMD allowed
•    Best corrected visual acuity of 6/18 to 6/96


Exclusion Criteria:
•    Previous subfoveal laser photocoagulation in study eye
•    Concurrent eye conditions that may require medical or surgical treatment within a year.


For further information, please email the Clinical Research Department at:

clinical.research@aucklandeye.co.nz  and include:
•    full name
•    email address
•    contact phone number
•    nature of inquiry

 

Categories: Referrer News

Auckland Eye - New Zealand Centre of Excellence for Eye Care